The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Riddle of Biofilm Resistance
Open accessAbstract
A biofilm is a population of cells growing on a surface and enclosed in an exopolysaccharide matrix. Biofilms are notoriously difficult to eradicate and are a source of many recalcitrant infections. The nature of bacterial biofilm resistance to antimicrobials is the subject of the present minireview. Pathogenic yeast such as Candida albicans also form recalcitrant biofilms, and this topic has recently been reviewed (5). Resistance is an ability of a microorganism to grow in the presence of an elevated level of an antimicrobial. In short, a strain for which the MIC is increased is resistant. By this conventional criterion, biofilm cells do not necessarily show increased resistance. With some exceptions, biofilm cells do not grow better than planktonic cells in the presence of a broad range of antimicrobials. This is evident from examination of susceptibility data in the biofilm literature (33). However, in most biofilm susceptibility studies, only survival of cells in a preformed biofilm rather than the ability of a biofilm to grow is recorded. Accordingly, the reported “resistance” describes an increased resistance of cells to killing. This is indeed what biofilms are good at: they are not easily eradicated by cidal antimicrobials. The ability of antimicrobials to inhibit biofilm growth indicates that they are able to diffuse through the biofilm and act normally against their targets. Why, then, do biofilm cells not die? This is the crux of the problem and the riddle that needs to be solved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 3×
“Slow growth undoubtedly contributes to biofilm resistance to killing (15).”
BackgroundEscherichia coli and Salmonella :cellular and molecular biology
Neidhardt, F. C. (1996) · ASM Press eBooks · Cited by 8,197
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00797.x · Cited by 2,537
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Pratt, L. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01061.x · Cited by 1,636
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Cited by
Items 101–164 of 164
Anderl, J. N., Zahller, J., Roe, F., & Stewart, P. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1251-1256.2003 · Cited by 355
Biofilm Forming Lactobacillus: New Challenges for the Development of Probiotics
Salas-Jara, M., Ilabaca, A., Vega, M., & García, A. (2016) · Microorganisms · doi:10.3390/microorganisms4030035 · Cited by 353
Srinivasan, R., Santhakumari, S., Poonguzhali, P., Geetha, M., Dyavaiah, M., & Xiangmin, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.676458 · Cited by 352
Microbial Biofilms and Chronic Wounds
Omar, A., Wright, J., Schultz, G., Burrell, R., & Nadworny, P. (2017) · Microorganisms · doi:10.3390/microorganisms5010009 · Cited by 348
Tiller, J. C., Lee, S. B., Lewis, K., & Klibanov, A. M. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.10299 · Cited by 338
Self-citationDIAGNOSIS AND MANAGEMENT OF INFECTION AFTER TOTAL KNEE ARTHROPLASTY
TSUKAYAMA, D. T., GOLDBERG, V. M., & KYLE, R. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200300001-00014 · Cited by 333
Biofilms: Formation, drug resistance and alternatives to conventional approaches
Mirghani, R., Saba, T., Khaliq, H., Mitchell, J., Do, L., Chambi, L., Diaz, K., Kennedy, T., Alkassab, K., Huynh, T., et al. (2022) · AIMS Microbiology · doi:10.3934/microbiol.2022019 · Cited by 333
Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments
Singh, S., Datta, S., Narayanan, K. B., & Rajnish, K. N. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00242-y · Cited by 331
Redefining the Persistent Infection in Root Canals: Possible Role of Biofilm Communities
de Paz, L. C. (2007) · Journal of Endodontics · doi:10.1016/j.joen.2006.11.004 · Cited by 326
Gilbert, P., Allison, D. G., & McBain, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.5.x · Cited by 323
Antimicrobial Plant Metabolites: Structural Diversity and Mechanism of Action
Radulovic, N. S., Blagojevic, P. D., Stojanovic-Radic, Z. Z., & Stojanovic, N. M. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713805219136 · Cited by 322
Action of Antimicrobial Peptides against Bacterial Biofilms
Yasir, M., Willcox, M. D. P., & Dutta, D. (2018) · Materials · doi:10.3390/ma11122468 · Cited by 319
Milović, N. M., Wang, J., Lewis, K., & Klibanov, A. M. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20454 · Cited by 315
Self-citationBacterial persisters: molecular mechanisms and therapeutic development
Niu, H., Gu, J., & Zhang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01866-5 · Cited by 310
Quave, C. L., Plano, L. R. W., Pantuso, T., & Bennett, B. C. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.05.005 · Cited by 310
Liao, C., Huang, X., Wang, Q., Yao, D., & Lu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926758 · Cited by 309
Borges, A., Abreu, A., Dias, C., Saavedra, M., Borges, F., & Simões, M. (2016) · Molecules · doi:10.3390/molecules21070877 · Cited by 308
Surpassing nature: rational design of sterile-surface materials
Lewis, K., & Klibanov, A. M. (2005) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.05.004 · Cited by 308
Self-citationZhou, L., Zhang, Y., Ge, Y., Zhu, X., & Pan, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.589640 · Cited by 301
Valdéz, J. C., Peral, M. C., Rachid, M., Santana, M., & Perdigón, G. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01142.x · Cited by 301
Metal Oxide Nanoparticles Against Bacterial Biofilms: Perspectives and Limitations
Shkodenko, L., Kassirov, I., & Koshel, E. (2020) · Microorganisms · doi:10.3390/microorganisms8101545 · Cited by 296
Enterococcal Surface Protein, Esp, Enhances Biofilm Formation by Enterococcus faecalis
Tendolkar, P. M., Baghdayan, A. S., Gilmore, M. S., & Shankar, N. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6032-6039.2004 · Cited by 295
Concepts and Principles of Photodynamic Therapy as an Alternative Antifungal Discovery Platform
Dai, T., Fuchs, B. B., Coleman, J. J., Prates, R. A., Astrakas, C., St. Denis, T. G., Ribeiro, M. S., Mylonakis, E., Hamblin, M. R., & Tegos, G. P. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00120 · Cited by 295
Kong, E. F., Tsui, C., Kucharíková, S., Andes, D., Van Dijck, P., & Jabra-Rizk, M. A. (2016) · mBio · doi:10.1128/mbio.01365-16 · Cited by 294
Molecular and Antibiofilm Approaches to Prosthetic Joint Infection
Trampuz, A., Osmon, D. R., Hanssen, A. D., Steckelberg, J. M., & Patel, R. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000087324.60612.93 · Cited by 293
Fungal Biofilms and Drug Resistance
Jabra-Rizk, M. A., Falkler, W. A., & Meiller, T. F. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1001.030119 · Cited by 292
Sandasi, M., Leonard, C. M., & Viljoen, A. M. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2009.02747.x · Cited by 292
Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond
Yin, R., Dai, T., Avci, P., Jorge, A. E. S., de Melo, W. C., Vecchio, D., Huang, Y.-Y., Gupta, A., & Hamblin, M. R. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.009 · Cited by 286
Antibiofilm activities of 1-alkyl-3-methylimidazolium chloride ionic liquids
Carson, L., Chau, P. K. W., Earle, M. J., Gilea, M. A., Gilmore, B. F., Gorman, S. P., McCann, M. T., & Seddon, K. R. (2009) · Green Chemistry · doi:10.1039/b821842k · Cited by 281
Coenye, T., Peeters, E., & Nelis, H. J. (2007) · Research in Microbiology · doi:10.1016/j.resmic.2007.02.001 · Cited by 270
In vivo biofilm composition of Aspergillus fumigatus
Loussert, C., Schmitt, C., Prevost, M.-C., Balloy, V., Fadel, E., Philippe, B., Kauffmann-Lacroix, C., Latgé, J. P., & Beauvais, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01409.x · Cited by 269
Bacterial biofilms: a diagnostic and therapeutic challenge
Fux, C. A., Stoodley, P., Hall-Stoodley, L., & Costerton, J. W. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.4.667 · Cited by 269
Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates
Smith, K., & Hunter, I. S. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47668-0 · Cited by 266
Interactions between Biocide Cationic Agents and Bacterial Biofilms
Campanac, C., Pineau, L., Payard, A., Baziard-Mouysset, G., & Roques, C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1469-1474.2002 · Cited by 263
An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus
Beauvais, A., Schmidt, C., Guadagnini, S., Roux, P., Perret, E., Henry, C., Paris, S., Mallet, A., Prévost, M.-C., & Latgé, J. P. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00895.x · Cited by 262
“…aerial environment resembles bacteria or yeast biofilms, which are defined as a struc- © 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd, Cellular Microbiology, 9, 1588–1600 tured microbial community of cells enclosed in an exopolysaccharide matrix (Lewis, 2001; Douglas, 2003).”
BackgroundInfluentialDuarte, S., Gregoire, S., Singh, A. P., Vorsa, N., Schaich, K., Bowen, W. H., & Koo, H. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00147.x · Cited by 259
Bacterial exopolysaccharides as emerging bioactive macromolecules: from fundamentals to applications
Kaur, N., & Dey, P. (2023) · Research in Microbiology · doi:10.1016/j.resmic.2022.104024 · Cited by 257
Biofilm in endodontics: A review
Jhajharia, K., Parolia, A., Shetty, K., & Mehta, L. (2015) · Journal of International Society of Preventive and Community Dentistry · doi:10.4103/2231-0762.151956 · Cited by 256
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222
Müller, A., Wolf, D., & Gutzeit, H. O. (2017) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2017-0030 · Cited by 218
“Additionally, microorganisms living in a biofilm are extremely resistant to antibiotic treatment reasoned by the bacteria-surrounding matrix that consists of extracellular polymeric substances (EPS) including proteins, polysaccharides and DNA [53, 54].”
BackgroundPersister Cells: Molecular Mechanisms Related to Antibiotic Tolerance
Lewis, K. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-28951-4_8 · Cited by 217
Self-citationThe effect of five common essential oil components on Listeria monocytogenes biofilms
Sandasi, M., Leonard, C. M., & Viljoen, A. M. (2008) · Food Control · doi:10.1016/j.foodcont.2007.11.006 · Cited by 204
Chorianopoulos, N. G., Giaouris, E. D., Skandamis, P. N., Haroutounian, S. A., & Nychas, G.-J. E. (2008) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03694.x · Cited by 202
Planktonic Aggregates of Staphylococcus aureus Protect against Common Antibiotics
Haaber, J., Cohn, M. T., Frees, D., Andersen, T. J., & Ingmer, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041075 · Cited by 187
Klein, M. I., Duarte, S., Xiao, J., Mitra, S., Foster, T. H., & Koo, H. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01299-08 · Cited by 154
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy
Wiederhold, N. P., & Lewis, R. E. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.8.1313 · Cited by 144
Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., Riccardi, G., Boon, N., Nelis, H. J., Mahenthiralingam, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058943 · Cited by 135
“In addition, biofilm-associated cells are often more tolerant to antimicrobials than planktonic cells [7] due to reduced drug penetration in the biofilm, the lower growth rate of sessile cells and/or the expression of specific resistance genes [8,9].”
Backgroundvan der Veen, S., & Abee, T. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01519-10 · Cited by 131
Recent developments in the use of nanoparticles for treatment of biofilms
Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L. (2017) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0054 · Cited by 114
Khot, P. D., Suci, P. A., Miller, R. L., Nelson, R. D., & Tyler, B. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-06 · Cited by 104
“In general, microbial biofilms exhibit an exceptional ability to survive doses of antimicrobial agents that are many times greater than the dose which is lethal for their planktonic counterparts (18, 22, 45, 68).”
BackgroundAbsence of Amphotericin B-Tolerant Persister Cells in Biofilms of Some Candida Species
Al-Dhaheri, R. S., & Douglas, L. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-07 · Cited by 99
Klebensberger, J., Birkenmaier, A., Geffers, R., Kjelleberg, S., & Philipp, B. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.02012.x · Cited by 97
Antifungal Combinations against Candida albicans Biofilms In Vitro
Bachmann, S. P., Ramage, G., VandeWalle, K., Patterson, T. F., Wickes, B. L., & López-Ribot, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3657-3659.2003 · Cited by 89
Klebensberger, J., Rui, O., Fritz, E., Schink, B., & Philipp, B. (2006) · Archives of Microbiology · doi:10.1007/s00203-006-0111-y · Cited by 85
Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation
Bandara, H. M. H. N., Yau, J. Y. Y., Watt, R. M., Jin, L. J., & Samaranayake, L. P. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.012989-0 · Cited by 82
Apoptosis in Candida biofilms exposed to amphotericin B
Al-Dhaheri, R. S., & Douglas, L. J. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.015784-0 · Cited by 81
“…that has gained considerable support in recent years involves the existence of a small number of drug-tolerant or persister cells – usually 1 % or less of the overall population – that neither grow nor die in the presence of microbicidal agents (Keren et al., 2004; Lewis, 2000, 2001, 2007).”
BackgroundGong, S.-Q., Niu, L.-N., Kemp, L. K., Yiu, C. K. Y., Ryou, H., Qi, Y.-P., Blizzard, J. D., Nikonov, S., Brackett, M. G., Messer, R. L. W., et al. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.05.031 · Cited by 75
Klebensberger, J., Lautenschlager, K., Bressler, D., Wingender, J., & Philipp, B. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01339.x · Cited by 70
Seth, A. K., Geringer, M. R., Galiano, R. D., Leung, K. P., Mustoe, T. A., & Hong, S. J. (2012) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.05.028 · Cited by 65
Bandara, H. M. H. N., K Cheung, B. P., Watt, R. M., Jin, L. J., & Samaranayake, L. P. (2013) · Molecular Oral Microbiology · doi:10.1111/omi.12006 · Cited by 57
Gong, S.-Q., Epasinghe, J., Rueggeberg, F. A., Niu, L.-N., Mettenberg, D., Yiu, C. K. Y., Blizzard, J. D., Wu, C. D., Mao, J., Drisko, C. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042355 · Cited by 53
Bacteriophage–host interaction: from splendid isolation into a messy reality
Brüssow, H. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.04.007 · Cited by 49
“Dormant cells might represent a natural stationary phase of bacteria responsible for the innate antibiotic resistant state of persister cells within biofilms [25].”
BackgroundEnvironmental Protection Strategies: An Overview
Malik, A., Rahman, M., Ansari, M. I., Masood, F., & Grohmann, E. (2012) · Environmental Protection Strategies for Sustainable Development · doi:10.1007/978-94-007-1591-2_1 · Cited by 11
Byeon, C., Kinney, T., Saricayir, H., Holst Hansen, K., Scott, F. J., Srinivasa, S., Wells, M. K., Mentink‐Vigier, F., Kim, W., & Akbey, Ü. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202418146 · Cited by 7
Metadata
- Authors
- Lewis, K.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2001-04
- Volume
- 45
- Issue
- 4
- Pages
- 999-1007
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2156788471
- Cited by
- 1,980
- References
- 67
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.